Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
申请人:Bayer Corporation
公开号:US06469031B1
公开(公告)日:2002-10-22
This invention is related to novel carboxyl substituted chroman derivatives which are useful in the treatment of beta-3 receptor mediated conditions.
这项发明涉及一种新型的羧基取代的色苷衍生物,可用于治疗β-3受体介导的疾病。